^
BIOMARKER:

BCL2 G101V

i
Other names: BCL2, Bcl-2, PPP1R50, B-cell CLL/lymphoma 2
Entrez ID:
BCL2 G101V
CLL
venetoclax + rituximab
Resistant: C3 – Early Trials
BCL2 G101V
CLL
venetoclax + obinutuzumab
Resistant: C3 – Early Trials
BCL2 G101V
CLL
BGB-11417
Sensitive: D – Preclinical
BCL2 G101V
CLL
venetoclax
Resistant: D – Preclinical